AKT1 and inflammatory bowel disease: Additionally, accumulating evidence also suggests that the PI3K/AKT signaling pathway is also involved in the pathogenesis of IBD, and inhibitors of PI3K/AKT have been proven to alleviate colonic inflammation [56,57,58].